Insider Insights

UK NHS England set to eliminate hepatitis C by 2030 as the first in the world  


NHS England has reported that following a five-year antiviral drugs deal worth almost £1 billion, deaths from Hepatitis C – including liver disease and cancer – have fallen by 35%. 

It has now exceeded the World Health Organization‘s target of 10% by more than three-fold and is on track to eliminate hepatitis C five years before the World Health Organization’s (WHO) overall 2030 target. 

The NHS’ hepatitis C elimination scheme has helped find and cure 70,000 people of the potentially fatal disease and reduced the number of people seeking liver transplants due to Hepatitis C by two-thirds within six years.  

In 2020, there were less than 50 liver transplant annual registrations among patients with Hepatitis C-related diseases, down from over 140 in 2015. This figure is expected to be even lower in 2022. 

The number of people needing liver transplants as a result of the virus has decreased by two-thirds in just six years, and in 2020, there will be less than 50 patients a year requiring a liver transplant who have Hepatitis C-related disorders. 

People in the most deprived communities have seen the biggest benefit, with 80% of treatments provided to the most deprived half of the population. 


  1. NHS set to eliminate Hepatitis C ahead of rest of the world. NHS England. Accessed 6th December 2022 
  2. NHS England set to be first in world to eliminate hepatitis C by 2030. PMLIVE. Accessed 6th December 2022 

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.